Updates From Trial of AveXis SMA1 Gene Therapy Trial Show Impressive Results in Most Infants – SMA News Today
SMA News Today |
Updates From Trial of AveXis SMA1 Gene Therapy Trial Show Impressive Results in Most Infants
SMA News Today Results from the first clinical trial of AVXS-101, a gene therapy for infants with spinal muscular atrophy (SMA) type 1, reveal dramatically improved survival as well as motor skills in most of the babies involved in the drug's first clinical trial … |
